PAMU
SRRA

Pictet Asset Management (UK)’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Pictet Asset Management (UK)’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-17,111
Closed -$4.3M – 860
2016
Q2 		$4.3M Buy
17,111
+15,493
+958% +$2.95M 0.02% 606
2016
Q1 		$381K Hold
1,618
– – ﹤0.01% 803
2015
Q4 		$973K Hold
1,618
– – ﹤0.01% 785
2015
Q3 		$1.33M Buy
+1,618
New +$1.82M 0.01% 761

Other funds holding SRRA

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Pictet Asset Management (UK)'s SRRA Position: Q3 2016 in Review

Pictet Asset Management (UK) sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2016, closing a stake of 17,111 shares — an estimated $4.3M sold.

Pictet Asset Management (UK) first reported a position in SRRA in Q3 2015 and held it in 4 quarters. The position peaked at $4.3M in Q2 2016. 42 funds tracked by Wall St. Rank hold SRRA as of Q3 2016.

  • Pictet Asset Management (UK) reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 17,111 Sierra Oncology, Inc. Common Stock shares in Q3 2016, an estimated $4.3M.
  • Pictet Asset Management (UK) first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 4 quarters.
  • Pictet Asset Management (UK)'s Sierra Oncology, Inc. Common Stock position peaked at $4.3M in Q2 2016.
  • 42 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2016.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2016, filed 14 Nov 2016.